参考文献/References:
【参考文献】 [1] Joaquin M A,Gianakos A L,Villa J C,et al.Current concepts on osteonecrosis of the femoral head[J].World Journal of Orthopedics,2015,6(8):590-601. [2] Arbab D,K nig DP.Atraumatic femoral head necrosis in adults [J].Deutsch Aerztebl Int,2016,113(3):31-38. [3] 陈宝琅.激素性股骨头坏死发病机制中细胞凋亡的研究进展[J].中国当代医药,2016,23(19):12-15. [4] 凌观汉,姚兰,欧志学,等.成人股骨头坏死早中期保髋治疗的研究进展[J].风湿病与关节炎,2017,6(4):60-64. [5] 何伟.如何把握股骨头坏死患者的保髋治疗时机[J].中国骨与关节杂志,2016(2):82-86. [6] 袁捷,张军,林吉,等.通络生骨胶囊治疗股骨头坏死的临床研究[J].中药新药与临床药理,2004,15(6):429-431. [7] 陈健,高勇,郭丽玲,等.CT、X 线在股骨头缺血性坏死Ficat、ARCO 和Steinberg 三种分期方法中的应用比较[J].医学临床研究,2017,34(1):122-124. [8] 袁捷,张军,林吉,等.通络生骨胶囊治疗股骨头坏死的临床研究[J].中药新药与临床药理,2004,15(6):429-431. [9] 袁捷,林吉,张军,等.通络生骨胶囊治疗股骨头坏死的Ⅲ期临床试验[J].亚太传统医药,2005(4):65-67. [10] 刘向春.活血化痰法配合髓芯减压、纳米人工骨植入术治疗早期SARS 股骨头坏死[D].北京:北京中医药大学,2007. [11] 李刚.通络生骨胶囊治疗激素性股骨头坏死临床与相关实验研究[D].广州:广州中医药大学,2005. [12] 李永吉.通络生骨胶囊治疗股骨头缺血性坏死(筋脉瘀滞型)的临床观察[D].黑龙江:黑龙江中医药大学,2016. [13] Zheng L,Wang W,Ni J,et al.The association of eNOS gene polymorphism with avascular necrosis of femoral head[J]. Plos One,2014,9(2):e87583. [14] Lei T,Qi W,Dang X,et al.Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid- induced femoral head osteonecrosis[J].BMC Musculoskeletal Disorders,2014,15(1):1-12. [15] Zeng X,Zhan K,Zhang L,et al.The impact of high total cholesterol and high low-density lipoprotein on avascular necrosis of the femoral head in low-energy femoral neck fractures[J].J Orthop Surg Res.2017,12(1): 30-36. [16] Kumar M N,Belehalli P,Ramachandra P.PET/CT study of temporal variations in blood flow to the femoral head following low-energy fracture of the femoral neck[J]. Orthopedics,2014,37(6):e563-e570. [17] Wang G,Zhang C Q,Sun Y,et al.Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis[J].Journal of International Medical Research,2010,38(3):1060-1069. [18] Mukisi M M,Bashoun K,Burny F.Sickle-cell hip necrosis and intraosseous pressure[J].Orthopaedics & Traumatology Surgery & Research,2009,95(2):134-138. [19] Jilka R L,Noble B,Weinstein R S.Osteocyte apoptosis[J]. Bone,2013,54(2):264-271. [20] Abu-Amer Y.NF-κB signaling and bone resorption[J]. Osteoporosis International,2013,24(9):2377-2386. [21] Peng B,Sun Y,Jin J,et al.Disturbance of the OPG/RANK/ RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis[J].Respiratory Research,2011,12(1):157. [22] 田润,尹爱武,王盼.木豆叶化学成分研究[J].湖南科技学院学报,2012,33(4):68-69. [23] 骆庆峰,孙兰,斯建勇,等.木豆叶芪类提取物对高脂模型小鼠血脂和肝脏胆固醇的降低作用[J].药学学报,2008,43 (2):145-149. [24] 刘少军,陈小俊,冯丽敏,等.通络生骨胶囊对大鼠应力缺失性骨质疏松的防治作用[J].中国实验方剂学杂志,2011,17 (6):170-173. [25] 郑元元,杨京,陈迪华,等.木豆叶提取物对人的类成骨细胞TE85 成骨功能和体外破骨细胞分化的影响[J].药学学报, 2007,42(4):386-391. [26] 郑元元,杨京,陈迪华,等.木豆叶芪类提取物对雌激素缺乏性大鼠骨质丢失的影响[J].药学学报,2007,42(5):562-565. [27] 陈迪华,斯建勇,潘瑞乐,等.一种用于治疗骨质疏松的药物组合[P].中国专利:CN1666745A,2005.9.14.